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Legionella pneumophila, a Gram-negative bacillus first identified in 1977, was the 
etiologic agent responsible for an outbreak of pneumonia that occurred in the American 
Legion Convention in 1976, Philadelphia. Although several other species of the genus 
Legionella were subsequently identified, this species is the most frequent cause of two 
distinct clinical syndromes: Legionnaires’ disease and Pontiac fever. 
The life cycle of Legionella pneumophila is divided in two distinct phases: a replicative 
phase followed by an infectious or transmissive phase. In the replicative phase the 
bacterium shows a nonmotile stage with a low or nonexistent toxicity. In the infectious 
phase the bacterium develops a flagellum becoming motile and highly toxic. 
The main hosts of Legionella pneumophila are amoeba and human macrophages. The 
interaction of the bacteria with these hosts shows several similarities, except for the 
death mechanism that it induces in order to evade before beginning a new infection 
cycle. In macrophages, this process has already been studied in great detail but in 
amoeba it has rarely been addressed and so far, the published data was based in only a 
few conditions of the infection. 
For a better understanding of this process we performed a study that considered several 
conditions of the infection. The results obtained in our study show a significant 
difference in the percentage of apoptotic cells between the Acanthamoeba castellanii 
infected by Legionella pneumophila and the uninfected Acanthamoeba castellanii. This 
data suggests that Legionella pneumophila induces apoptosis in amoeba and that the 
process of killing and exiting the macrophages by apoptosis may have evolved from the 
interaction with amoeba in the environment. 
  




Legionella pneumophila, um bacilo Gram-negativo identificado pela primeira vez em 
1977, foi o agente etiológico responsável pelo surto de pneumonia que ocorreu na 
Convenção da Legião Americana em 1976, em Filadélfia. Apesar de muitas outras 
espécies do género Legionella terem já sido identificadas, esta espécie é a causa mais 
frequente de duas síndromes clínicas distintas no Homem: a Doença dos Legionários e a 
Febre de Pontiac. 
O ciclo de vida da Legionella pneumophila divide-se em duas fases: a fase replicativa 
seguida por uma fase infecciosa ou transmissiva. Na fase replicativa a bactéria 
apresenta-se numa fase não-móvel e com uma toxicidade baixa ou quase inexistente. Na 
fase infecciosa a bactéria desenvolve um flagelo tornando-se móvel e altamente tóxica. 
Os principais hospedeiros de Legionella pneumophila são as amibas e os macrófagos. A 
interacção da bactéria com estes hospedeiros mostra várias semelhanças, à excepção do 
mecanismo de morte que induz para se evadir antes de iniciar um novo ciclo de 
infecção. Nos macrófagos este processo já foi estudado em grande detalhe mas nas 
amibas raramente tem sido explorado e os dados reportados até agora são baseados em 
poucos parâmetros da infecção. 
De modo a esclarecer melhor este processo, procedemos a um estudo mais abrangente 
considerando várias condições de infecção. Os resultados obtidos no nosso estudo 
mostraram que existe uma diferença significativa na percentagem de células apoptóticas 
entre Acanthamoeba castellanii infectadas por Legionella pneumophila e 
Acanthamoeba castellanii não-infectadas. Estes dados sugerem que Legionella 
pneumophila induz apoptose nas amibas e que o processo de morte e evasão dos 
macrófagos por apoptose pode ter evoluído da interacção com as amibas no ambiente. 
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Chapter 1. Introduction 
 
In late July 1976, the Centers for Disease Control and Prevention (CDC) in Atlanta, 
Georgia, responded to an epidemic of respiratory disease that affected the attendees of 
the 58th annual convention of the American Legion, Department of Pennsylvania, held 
in Philadelphia. Although the cause and etiologic agent were unknown, the disease 
appeared to be characterized by flu-like symptoms [1].  
By early August, the first deaths from pneumonia among men who had attended the 
convention began to be reported by news organizations from all over the country. Since 
by that time the cause of the illness was yet to be determined, the new threat was named 
“Legionnaires’ Disease” (LD) [2]. 
To investigate the cause of the outbreak, the CDC sent to the field the largest team in 
the center’s history to that date (32 people). The team was led by David Fraser and 
included 20 epidemiologists. The initial findings revealed that in total, 182 people met 
the criteria of a case, from which 29 died. Additionally, the team identified 39 people 
that showed a similar illness but had not attended the convention. These people had only 
been within a block of the hotel and the cases were called “Broad Street pneumonias” 
[3]. 
In order to identify the etiologic agent of LD, the team began to examine patients' serum 
and tissue specimens in a search for toxins, bacteria, fungi, chlamydiae, rickettsiae and 
viruses. With samples from the lungs of four patients (from a total of six) they were able 
to isolate a Gram-negative, nonacid-fast bacillus in guinea pigs. However, the 
classification of the organism was still incomplete [4]. 
Later on, using deoxyribonucleic acid (DNA) relatedness, Joseph McDade and 
colleagues showed that all strains of the LD bacterium were members of the same 
species and that the DNA from the LD bacterium was not significantly related to DNA 
from any other group of bacteria already known. Considering these data, in April 1979, 
they proposed that the LD bacterium should be named Legionella pneumophila and the 
type strain Philadelphia 1 [5]. 
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1.1. Legionella pneumophila: Physiology and Ecology 
 
The most well-known species, Legionella pneumophila (Lp), has a biphasic life cycle 
that features two phenotypically distinct phases: a replicative phase, where Lp shows a 
nonmotile shape; and a transmissive phase where Lp is highly virulent and flagellated 
[6, 7]. 
Legionella spp. is highly pleomorphic since it can alternate between coccoid, bacillary 
(~0.3 to 0.6µm by ~3µm) and long filamentous (~8 to 50µm) forms [8]. These 
pleomorphic changes are influenced by factors like temperature, nutrient availability, 
growth environment (e.g., as intracellular parasite) and the medium type [9, 10, 11, 12]. 
The bacterium are ubiquitous in aquatic environments and can be found in several 
freshwater habitats worldwide (e.g. rivers, lakes, streams, ponds, hot spring) [13, 14, 15, 
16] and some species have also been found in potting mixes [17, 18, 19] and soil [20, 
21, 22]. 
At the time of writing, the genus Legionella comprised approximately 56 distinct 
species (and many unnamed species) including at least 70 serogroups. Despite only half 
of them were isolated from, or identified in, clinical samples, all species are considered 
potential human pathogens [8]. 
Over 90% of the isolates associated with LD are Lp, and serogroup 1 (sg1) was 
identified in 83% of the cases [23]. 
In natural aquatic environments, Lp thrives at 25ºC to 37ºC [9], and is able to establish 
within biofilm communities or persist as facultative intracellular parasite that can invade 
and replicate inside amoebae [6]. Once ingested by the amoeba, Lp is able to avoid 
ingestion and begins to highly replicate inside the protozoan host. Once nutrients 
become limited, Lp induces the host death in order to evade and begin a new infection 
cycle [7]. 
Inside host cells Lp differentiates into a replicative form and when nutrients become 
limited into a transmissive form (Figure 1) [7]. Garduño et al. have shown that Lp can 
differentiate in vivo in Tetrahymena tropicalis directly from the transmissive form into 
a highly infectious mature intracellular form (MIF), indicating that transmissive form 
and MIFs constitute a differentiation continuum. In addition, MIFs are thought to be the 
infectious forms implicated in the transmission of LD [24]. 
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Much has been learnt about the epidemiology of LD and Legionella since the organism 
was first identified in 1976. In the meantime, surveillance schemes for LD have been 
applied in several countries including the USA, Canada, New Zealand, Australia, Japan, 
Singapore, and Europe, where LD became a notifiable disease and coordinated 
European surveillance has been established since 1995 [25]. 
In Portugal, LD was included in the Portuguese system of mandatory notifications of 
infectious diseases in 1999 and in 2004 an Integrated Programme of Epidemiological 
Surveillance was implemented in order to improve reporting (clinical and laboratory 
notification) [26]. 
Despite being a notifiable disease, LD is likely to be underestimated in many countries 
mainly because of the lack of common definitions, diagnostics and surveillance 
Figure 1 - The life cycle of Lp. 
1. Free-swimming transmissive Lp that are engulfed by the phagocyte host (amoeba) establish 
vacuoles that provide protection from lysosomal digestion. 
2. When nutrients and other conditions are favorable, intracellular bacteria repress transmission traits 
and activate pathways that promote replication. 
3. As conditions in the replication compartment become unfavourable, the progeny stop dividing and 
coordinately express traits that promote survival in the environment and transmission to a new phagocytic 
host. 
4. After a long period, the microbes may continue to develop into a mature intracellular form (MIF), a 
cell type that is highly resilient and infectious. 
5. The amoeba is lysed, and the microbes are released into the aqueous environment. 
6. Lp that do not immediately encounter a new phagocyte probably establish biofilms in both water 
systems and ponds, where they are resistant to biocidal agents.  
7. When planktonic microbes encounter a new phagocyte, the cycle begins anew (Adapted from [7]) 
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systems. This fact makes it impossible for LD to be directly comparable between 
countries [25]. 
The distribution of LD cases by age and gender is similar between countries: the disease 
is rare in children and more frequent in older people (74-91% of patients are ≥50 years) 
and males account for the majority of the notifications (1.4-4.3 male patients for every 
female patient) [27-31]. In Europe, the age-standardized notification rate of LD was 
10.7 per million people in 2013 and the number of notifications per million inhabitants 
was 11.4 [23].  
Several studies have shown that LD has a seasonal pattern that is associated with 
warmer and wetter weather conditions [32-35]. There is also evidence that suggests that 
the persistence of Lp is increased in aerosols at high relative humidity [36, 37]. 
There is also an association between LD cases and a history of recent travel, particularly 
involving overnight stays in hotel accommodations. Rooms that have not been used for 
a long time and the presence of large numbers of water outlets with long pipe runs can 
contribute to water stagnation, which will promote Legionella spp. growth, unless 
adequate control measures are applied [38, 39]. Cruise ships can also be sources of 
Legionella for similar reasons, and have already been associated with several outbreaks 
[40].  
In view of the association with travel, specific surveillance systems for travel-related 
cases of LD have been implemented in order to improve source identification and public 
health action [40]. 
In Europe, the surveillance of LD is carried out by the European Legionnaires’ disease 
Surveillance Network (ELDSNet) since 2010 and is coordinated by the European 
Centre for Disease Prevention and Control (ECDC). ELDSNet works in partnership 
with several entities like the World Health Organization (WHO), public health 




Transmission of LD is usually by inhalation of aerosols or aspiration of water 
containing Legionella spp. and until the present year no evidence of person-to-person 
transmission existed [25]. However, there has been documented recently (February, 
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2016) by Correia et al [42] a probable case of Lp transmission between two individuals 
after a cluster of cases of LD occurred in Vila Franca de Xira, Portugal, in 2014. The 
second patient is believed to have been infected by the first patient since the second 
patient was not geographically linked to the cluster epicenter and strains of both patients 
showed the novel ST1905 profile (identified as the causative strain in the cluster) [43]. 
In cases of LD where the etiologic agent is Legionella longbeachae, the transmission 
route is not well known to date, but it is believed to have a different source. In these 
cases, activities like exposure to potting compost or soil or poor hand-washing practices 





















Figure 2 - Route of Legionella dissemination from natural waters to human exposure. Legionella from 
freshwater sources (1) is distributed at low concentrations from points of water purification (2) to colonize 
downstream local plumbing networks and cooling systems (among other sites) (3) and amplifies under 
permissive environmental conditions (4). Subsequent aerosolization (5) exposes a human population (6), 
leading to a potential disease spectrum. The route of LD caused by contaminated soil is less well 
understood but also appears to involve aerosol exposure (Adapted from [8]). 
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Contaminated cooling towers have been associated with the largest outbreaks of LD 
(Murcia, Spain, in 2001 with 449 confirmed cases and Vila Franca de Xira, Portugal, in 
2014 with 334 confirmed cases) [43, 47-49]. Hot and cold water systems and whirlpool 
spas have also been shown to be sources of transmission [50, 51]. 
In fact, a great number of LD outbreaks have been shown to be linked to aerosol-
producing devices as the source of Legionella spp. transmission and a major variety of 
mechanisms and settings (e.g. evaporative air conditioning units, decorative fountains 
and showers) have been described [52, 53]. 
 
1.4. Clinical Presentation 
 
In humans, Legionella can cause two distinct clinical syndromes: Pontiac Fever (PF) 
and LD [54]. PF is an acute, self-limited form of legionellosis characterized by flu-like 
symptoms and was named after an explosive outbreak that occurred in the city of 
Pontiac, in Michigan, USA [55]. 
LD, the most severe form of legionellosis, is characterized by pneumonia that can be 
associated with systemic infection [25]. LD does not have specific, defining clinical 
features because it presents as a variety of clinical manifestations and symptoms (e.g., 
fever, myalgia, cough, and pneumonia) [56-58]. The incubation period of LD is thought 
to be 2–10 days (median 6–7 days); however, longer incubation periods have been 
reported [48, 51]. In the last years, the mortality from LD has decreased, probably due 




The diagnosis of LD can be a challenging process, considering that the clinical 
symptoms are often indistinguishable from other causes of pneumonia. Considering this 
fact, laboratory confirmation becomes essential for an accurate diagnosis [60]. There are 
several laboratory-based methods for the LD diagnosis, which can be divided in two 
major groups: phenotypic and genotypic methods. The phenotypic methods currently 
used are urinary antigen test (UAT), serum antibody titration and culture; the genotypic 
methods are based on the Polymerase Chain Reaction (PCR) [61].  
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Figure 3 shows the anatomical locations of each specimen type used for the LD 



















Current LD case classification is divided in probable and confirmed case. Probable case 
is defined when any person has pneumonia and at least one of the following four 
laboratory criterion: detection of Lp antigen in respiratory secretions or lung tissue, for 
example by Direct Fluorescent Antibody (DFA) staining using monoclonal-antibody 
derived reagents; detection of Legionella spp. nucleic acid in respiratory secretions, 
lung tissue or any normally sterile site; significant rise in specific antibody level to Lp 
other than sg 1 or other Legionella spp. in paired serum samples; or single high level of 
specific antibody to Lp sg 1 in serum. Confirmed case is defined when any person has 
pneumonia and at least one of the following three laboratory criterion: isolation of 
Legionella spp. from respiratory secretions or any normally sterile site; detection of Lp 
sg1 antigen in urine or significant rise in specific antibody level to Lp sg 1 in paired 
Figure 3 - Anatomical locations of each specimen type used for Legionella detection and the 
specific diagnostic tests. The clinical identification of Legionella can be made by several assays and 
different specimens. Some assays can be applied to multiple specimen types, such as culture and nucleic 
acid amplification. Although it is not recurrent, Legionella infection at extrapulmonary sites can also be 
observed (Adapted from [8]). 
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serum samples [62]. 
In the following sections, four diagnostic tests will be described in greater detail: 




Despite the improvements in other diagnostic tests, isolation by culture remains the gold 
standard for Legionella detection and LD diagnosis. Is the most specific test and 
requires special media, adequate processing of specimens, and technical expertise [63].  
Legionella can be cultured from a number of specimens, including respiratory 
secretions (sputum, bronchial alveolar lavage (BAL), and bronchial aspirates), lung 
tissue/biopsy, serum, blood and stool [64, 65]. However, the preferable specimens are 
the lower respiratory tract secretions (e.g. sputum), which should be promptly processed 
since Legionella may survive poorly in these secretions [64].  
Reports of Legionella infection at extrapulmonary sites are rare, but have already been 
verified. In those cases, the samples are collected from soft tissues, joint fluids, and 
blood and culture should be attempted only when other etiologies have been ruled out 
since the recovery of an isolate is extremely difficult [8]. 
The standard medium used to culture Legionella spp. is the Buffered Charcoal Yeast 
Extract (BCYE-α) agar, and contains yeast extract, activated charcoal, α-ketoglutarate, 
L-cysteine and soluble ferric pyrophosphate. The pH of the agar must be adjusted to 6.9 
with the addition of ACES (N-2-acetamido-2-aminoethansulfonic acid) buffer in order 
to enhance bacterial growth [66] and the optimum growth temperature is 37ºC.  
The main disadvantage of this method is the fact that it requires several days to obtain a 









Figure 4 – Culture of Lp in BCYE-α agar with 4 days of incubation (photo obtained in the present 
study). 
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1.5.2. Urinary Antigen Test 
 
The UAT for the diagnosis of LD is available since 1980 [59] and it has become the 
first-line diagnostic test [67]. Its use has been increasing over the years, surpassing other 
diagnostic methods, mainly because it is fast, easy to perform and provides timely, 
accurate results, with high sensitivity (70%-80%) and specificity (>95%) [68].  
The urinary antigen in question is a component of the cell wall LPS of Lp and is 
detected by an enzyme immunoassay (EIA), early in the course of the illness [67, 61, 
69]. The test becomes positive after 48-72h of the beginning of the symptoms [67], and 
the antigen may continue to be excreted in detectable quantities in urine for several 
months, even after appropriate treatment and apparent recovery from infection, which 
becomes a disadvantage for diagnosis [69]. However, it has been shown that in the 
majority of cases antigenuria became negative within 2 months after the first diagnosis 
[70]. 
At present, the Legionella UAT is available in two main formats: a 96-well plate-based 
EIA or ELISA, and a rapid immunochromatographic test, in a card/strip-based format, 
similar to a home pregnancy test (Figure 5) [8]. 
However, despite being a valuable tool, the UAT only detects the most prevalent 
species and serogroup, Lp sg1 (the causative agent in 70%-80% of LD cases), which 















Figure 5 – Rapid diagnostic test for detection of Lp antigen in urine. 
(Available at http://www.corisbio.com/images/Products/Procedure/full/Legionella-V-TesT.jpg). 
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1.5.3. Serological assays 
 
Serological testing was one of the main methods used for LD diagnosis in the early 
1980s [59]. Nowadays, this method is useful for cases where the patients have already 
started antibiotherapy or when it is difficult to obtain respiratory samples. It is 
considered a late diagnostic because it requires a paired serum samples with 2 weeks 
apart. 
The main disadvantage of the serological assays is the possibility of cross-reactivity 
between different serogroups or between different species of Legionella spp., which 
may interfere with the interpretation of the results and therefore influence the diagnosis, 
leading to incorrect and ineffective treatment [72, 73]. 
Nevertheless, serology remains important for LD confirmation in the cases where the 
etiologic agent cannot be isolated. Furthermore, this method may be of interest for 
retrospective epidemiological studies, such as general seroprevalence, to identify 
patterns of disease or potential ongoing outbreaks [8]. 
 
1.5.4. Polymerase Chain Reaction 
 
The first report of PCR as a method to detect Legionella was in 1989 [74] and since 
then it has become frequently used to identify Legionella in clinical samples [75]. 
PCR enables specific amplification of small amounts of Legionella DNA, provides 
rapid diagnosis (with outcome in a day) and is one of the few diagnostic tests with the 
potential to detect infections caused by all of the known species and serogroups of 
Legionella spp. [63, 67, 75]. 
It has been successfully used to detect Legionella DNA in a range of clinical samples, 
such as sputum, urine and serum. However, the reliableness of the results obtained from 
nonrespiratory specimens is not fully known [63].  
Previous tests with samples from the lower respiratory tract have shown that PCR is 
highly specific and has sensitivity greater than culture, suggesting that it is suitable for 
use in the routine microbiological diagnostic laboratory [76]. 
Additionally, this method can be used when the patient have already started the 
antibiotherapy [77]. 
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Despite all the advantages, the difficulty in assessing bacterial viability is the main 
disadvantage of all nucleic acid amplification methods, since they fail to discriminate 
between nucleic acids from dead or dying bacteria. Therefore, they cannot distinguish 
disease resolution from current disease [8]. 
 
1.6. Management and Risk Factors 
 
When a case of LD is diagnosed, the physicians must be aware of the possible presence 
of other cases related in time and place, which can be crucial for identification of the 
potential source of infections. It is also important to have a detailed history of the recent 
activities of the patient, including any potential exposure to aerosolized water droplets 
(especially during the previous 10 days) in order to support the epidemiological follow-
up, trace any other patients and identify the source of infection [25].  
LD can occur in previously healthy individuals, but is more frequent in those who 
gather the major risk factors, such as age (≥50 years), sex (male), smoking habits, 
chronic cardiovascular/respiratory disease, diabetes, alcohol misuse, and 
immunosuppression (e.g. after solid organ transplantation or any other 
immunosuppressive therapy). Immunosuppressed patients might present with more 
severe clinical disease and frequently require intensive care, intravenous antibiotics, and 
a longer duration of therapy [78-81].  
The empiric therapy for LD is antibiotic treatment of the infection and management of 
any complications [58]. The chance of recovery is higher if the appropriate antibiotics 
are given early [57, 82]. Since LD does not have any defining clinical features and that 
β-lactam antibiotics (usually used to treat bacterial community-acquired pneumonia) are 
unsuccessful for treatment of LD, it is wise to give effective antibiotic therapy against 
Legionella spp. in the early stage of all moderate-to-severe community-acquired and 
hospital-acquired pneumonias, until a specific microbiological diagnosis is made. The 
dose and route of administration of treatment (which can be either oral or intravenous) 
is guided by severity, underlying risk factors, consciousness level, and gastrointestinal 
disorders [25].  
Because Lp is an intracellular pathogen residing within tissue and alveolar 
macrophages, successful treatment depends on use of antibiotics that achieve 
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therapeutic intracellular concentrations within macrophages, such as the macrolides and 
fluoroquinolones [83-88]. Erythromycin had been the drug of choice for treatment of 
LD until the 1990s but its use have been decreasing since it is bacteriostatic and has 
side-effects, particularly when used intravenously [89, 90]. However, the newer 
macrolides such as azithromycin have fewer side-effects. Regarding fluoroquinolones, 
they are bactericidal and in vitro their activity against Legionella spp. in animal models 
has been shown to be higher the one from erythromycin [91, 92]. 
 
1.7. Legionella pneumophila natural host: Acanthamoeba spp. 
 
Amoebae are ubiquitous organisms that can be found in humid soil and water 
reservoirs, being the most common genus Acanthamoeba spp. [93, 94]. They are 
unicellular protozoans that can display two different phases during their life cycle, 
according to the environmental conditions. When the conditions are unfavorable to their 
growth (e.g. limited nutrients, temperature) they remain as a dormant cyst, a process 
called encystment. Conversely, when the conditions are suitable for their growth, they 
change to an active vegetative trophozoite, a process called excystment [94]. 
Free-living amoebae are frequently isolated from several man-made reservoirs, such as 
tap water, air-conditioning units, and cooling towers, where they feed on the existing 
microbial biofilm. However, though amoebae are bacterial predators, several bacteria 
have developed mechanisms to survive phagocytosis, being able to use the amoebae as 
hosts [95]. 
Transient association with amoebae has been reported for a number of different bacteria 
including Lp, many Mycobacterium spp., Francisella tularensis, and Escherichia coli 
O157, among others [96-99]. 
Since most of these bacteria are pathogens of humans, it has been suggested that 
protozoa have an important role in the development of bacterial pathogenesis and that 
the interaction bacteria/protozoa is significant in terms of human disease [100]. 
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1.7.1. Life cycle in Acanthamoeba spp. 
 
Lp is ubiquitous in freshwater, often in close association with freshwater protozoa [95] 
and replicates at temperatures of 25–42°C with an optimal growth temperature of 35°C. 
Consistent with what Lp would encounter in the environment, motility and adherence to 
host cells are optimal at temperatures below 37°C [101]. 
Thermal conditions have been shown to affect the interaction between Lp and amoebae 
[102]. At temperatures over 25°C Lp is able to infect the trophozoite form of free-living 
amoebae and replicate intracellularly, increasing the number of bacteria in the water. 
Consequently, the chance of transmission to humans increases as well [102, 103]. In 
contrast, with temperatures below 20°C, the amoebae encyst and Lp is not able to 
replicate inside the host [63]. 
Intracellular Lp is capable of survival within this cysts that ensure their survival by 
protecting them from harsh environments. In this stage, the bacteria are not capable to 
proliferate and thrive to a dormant state [104]. 
Fourteen species of amoebae, with Hartmannellae and Acanthamoeba being the most 
prominent, and two species of ciliated protozoa have been shown to support 
intracellular replication of Lp [95]. When compared with bacteria grown in vitro, 
bacteria grown in amoebae have an increased resistance to harsh conditions [105, 106] 
and show changes in biochemistry, physiology, and virulence potential [103]. From 
those changes it has been verified: an enhanced resistance to chemical disinfectants, 
treatment with biocides and antibiotics [95]; shorter size and larger diameter; different 
protein expression [107]; enhanced intracellular survival and replication and increased 
ability to infect not only amoebae but also mammalian cells [108]. It has also been 
shown that amoeba are capable of resuscitate viable non-culturable Lp, for instance after 
disinfection [95, 109, 110]. Additionally, it is believed that the enhanced infectivity of 
Lp after growth within amoebae may compensate the low concentration of bacteria 
usually detected in the aquatic reservoirs from which the bacteria are transmitted to 
humans during LD outbreaks [111-114]. 
Besides enhancing the pathogenicity of Lp, amoebae are also responsible for their 
persistence in the environment. Since Legionella species cannot multiply 
extracellularly, the presence of amoebae as hosts in their life cycle is fundamental 
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1.7.2. From Amoebae to Macrophage 
 
Lp are able to infect, multiply within, and kill human macrophages, as well as free-
living amoebae [116]. This ability is thought to be a consequence of previous 
interaction with several protozoan hosts that allowed Lp to adapt to intracellular growth 
within macrophages [117]. This adaptation process is thought to include the acquisition 
of eukaryotic genes during its co-evolution with amoebae [118], which is supported by 
Figure 6 - The environmental life cycle of Lp within protozoa. 
1. Flagellated Lp infects protozoa in the aquatic environment. 
2. The Legionella-containing vacuole (LCV) evades the default endosomal–lysosomal degradation 
pathway and becomes rapidly remodeled by the ER through intercepting ER-to-Golgi vesicle 
traffic. 
3. Under unfavorable stress conditions, such as nutrient deprivation, amoeba encysts, and bacterial 
proliferation will not occur due to nutrient limitation. 
4. During late stages of infection, the LCV becomes disrupted leading to bacterial egress into the 
cytosol where the last 1–2 rounds of proliferations are completed. Nutrient depletion triggers a 
phenotypic transition into a flagellated virulent phenotype followed by lysis of the amoeba and 
bacterial escape from the host cell. Excreted vesicles filled with bacteria are also released. The 
infectious particle is not known but may include excreted Legionella-filled vesicles, intact 
Legionella-filled amoeba, or free Legionella that have been released from host cell. 
5. Transmission to humans occurs via aerosols generated from man-made devices and installations, 
such as cooling towers, whirlpools, and showerheads (Adapted from [115]). 
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findings that show that all the genes that are required for intracellular growth in human 
macrophages are the same required for intracellular growth in Acanthamoeba castellanii 
(Ac) [116]. 
Additionally, the life cycle of Lp in macrophages strongly resembles the one observed 
in amoebae, mainly in the process by which Lp is able to avoid digestion. In both 
phagocytes vacuoles containing Lp neither acidify nor fuse with the lysosomal 
compartment, allowing the association between the phagosome and the endoplasmic 
reticulum which leads to the high intracellular replication of Lp [119]. 
Moreover, the similar cell biology between amoebae and macrophages can also be an 
indicator that the virulence of Lp for macrophages is in fact a consequence of its 
evolution as an intracellular parasite of protozoa [119]. 
Lp and amoebae have been isolated from the same source of infection during outbreaks 
of LD [95] which shows that amoeba are a natural reservoir for the opportunistic 
pathogens of macrophages [119]. 
 
1.7.3. Evasion of the host for new infection cycle 
 
The ability to lyse and exit host cells after intracellular replication is an essential step in 
the life cycle of all intracellular pathogens [120]. After this step, the released pathogens 
are able to infect other cells within the same host or be transmitted to a new susceptible 
host [120]. 
It is known that Legionella has the ability to kill a wide variety of host cells (e.g. human 
phagocytic cells, amoeba and ciliated protozoa) and it has been suggested that the 
bacteria induce apoptosis, or programmed cell death, in the host [121]. 
Furthermore, it has been shown that Lp is able to induce major changes in the nuclear 
morphology of the host as well as increase the proportion of fragmented DNA, which 
correlates with the cell death process that occurs in macrophage-like HL-60 cells [122]. 
Even though this issue has already been addressed, apoptotic death of amoeba infected 
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The first studies dedicated to cell death date back to the nineteenth century and were 
generally related to the metamorphosis of tadpoles and insects, and later with transient 
embryonic structures [123, 124]. The subject of “programmed cell death” – in which 
“apoptosis” is included as one type of cell death -  appeared later in the 1970s when 
scientists first began to observe a sequence of events in the cell that once established 
could lead to its death. These observations showed that cell death during development is 
not of accidental nature but instead follows a sequence of controlled steps that lead to 
self-destruction of the cell [124]. 
The term “apoptosis” was then proposed in 1972 to name one type of programmed cell 
death that plays an important role in the regulation of animal cell populations. 
Moreover, it was shown that the apoptotic process could be initiated or inhibited by a 
variety of environmental stimuli, both physiological and pathological [125]. 
Since then, the field of apoptosis research began to grow exponentially with a new set 
of mind in which cell death is not an incidental part of life, but instead a highly 
controlled and medically important element of existence [124, 126]. 
Although apoptosis is the most frequent form of programmed cell death, it is important 
to note that there are other non-apoptotic types of programmed cell death that have 
already been described and have biological significance [127, 126]. 
 
1.8.1. Morphological features of apoptosis 
 
When a cell is triggered to suffer apoptosis it means that a cascade of molecular events 
has been activated, resulting in the total disintegration of the cell [128]. 
One of the first events of this type of “programmed cell death” is the loss of 
intracellular water, which leads to a smaller and denser cell. Later, one of the most 
characteristic features of apoptosis occurs: the condensation of the nuclear chromatin to 
heterochromatin (in one or more masses in the nucleus). The nuclear membrane of the 
cell begins to disintegrate and lamin proteins undergo proteolytic degradation, followed 
by nuclear fragmentation. Activation of endonuclease(s) results in a selective 
degradation of DNA, in fragments up to 50–300kb, and is followed (in many but not all 
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cell systems) by internucleosomal DNA cleavage. As a result, many nuclear fragments 
(that resemble with DNA droplets of different sizes) are then scattered throughout the 
cytoplasm. Afterwards, those nuclear fragments, together with constituents of the 
cytoplasm (e.g. undamaged organelles), are packaged and enclosed by fragments of the 
plasma membrane. These structures, named ‘‘apoptotic bodies’’, are then shed from the 
dying cell (Figure 7) [124, 128]. 
During this process, there are two important characteristics that are exclusive of 
apoptosis: the activation of endonuclease(s) that preferentially cleave DNA at the 
internucleosomal sections and the preservation of the structural integrity of the plasma 
membrane as well as some cellular organelles, such as mitochondria and lysosomes 
[128]. 
Opposing to apoptosis, there is a different type of cell death that can be interpreted as an 
“accidental death”, named necrosis [126]. In this case, the cell death pathway begins 
with the mitochondrial swelling that eventually leads to the rupture of the plasma 
membrane, which causes the releasing of the cytoplasmic constituents. At the end of 
this process, nuclear chromatin shows irregular areas of condensation and the nucleus is 














Figure 7 – Morphological and biochemical changes that occur during apoptosis and necrosis. The 
apoptotic pathway begins with the loss of intracellular water and increase in the concentration of ionized 
calcium in the cytoplasm, resulting in the cell shrinkage. Subsequently, the chromatin condensation occurs 
followed by nuclear disintegration and formation of apoptotic bodies. The integrity of the plasma 
membrane is preserved to the late stages of apoptosis. In contrast, the necrotic pathway begins with the 
swelling of mitochondria as well as swelling of the whole cell, combined with marginal chromatin 
condensation. Finally, the rupture of the plasma membrane results in the releasing of the cytoplasmic 
content of the cell (Adapted from [128]). 
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1.8.2. Mechanisms of apoptosis 
 
The apoptotic machinery is tightly controlled and can be initiated by two main 
alternative pathways: the death-receptor pathway (usually named “extrinsic pathway”); 
or the mitochondrial pathway (usually named “intrinsic pathway”) [129, 126]. 
Both pathways have in common the presence of initiator cysteine aspartyl-specific 
proteases, called caspases (caspase-8 for the extrinsic pathway and caspase-9 for the 
intrinsic pathway) that once activated cleave and activate the ‘executioner’ caspases, 
such as caspase-3, which starts the execution pathway and is common to both extrinsic 
and intrinsic pathways. The active executioner caspases then cleave each other and an 
amplifying proteolytic cascade of caspase activation is started. Ultimately, the active 
executioner caspases cleave cellular substrates leading to the characteristic biochemical 




Figure 8 - The two main apoptotic signalling pathways. Apoptosis can be initiated by two alternative 
pathways: either through death receptors on the cell surface (extrinsic pathway) or through mitochondria 
(intrinsic pathway). Both of them require specific triggering signals to begin an energy-dependent 
cascade of molecular events. Each pathway activates its own initiator caspase (8 and 9) which in turn will 
activate the executioner caspase-3. The execution pathway results in characteristic cytomorphological 
features including cell shrinkage, chromatin condensation, formation of cytoplasmic blebs and apoptotic 
bodies and finally phagocytosis of the apoptotic bodies by adjacent parenchymal cells, neoplastic cells or 
macrophages (Adapted from [126]). 
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1.8.3. Biochemical features  
 
There are several biochemical hallmarks of apoptosis (e.g. DNA degradation, protein 
cleavage, protein cross-linking, phagocytic recognition) that can be used to identify this 
mode of cell death [126]. 
One of those biochemical features is the expression of cell surface markers in the outer 
leaflet of the cell membrane. This membrane alteration allows the apoptotic cells to be 
recognized by adjacent cells, allowing a quick phagocytosis [126, 130]. 
Phosphatidylserine (PS) is an anionic phospholipid of the cellular membrane that in 
normal cells is only present in the inner membrane. During apoptosis, the amount of 
phosphatidylserine (PS) on the outer surface of the membrane increases, becoming 
exposed outside the cell [130]. 
For the study of apoptotic cells, a recombinant phosphatidylserine-binding protein 
named Annexin V can be used to detect this type of cells. Annexin V has been shown to 
interact strongly and specifically with phosphatidylserine residues, which makes it a 
















Figure 9 – Phosphatidylserine exposure during apoptosis. During apoptosis, the distribution of neutral 
phospholipids (black symbols) and anionic phospholipids such as PS (red symbols) in the cell membrane 
changes. PS is present in the outer membrane of apoptotic cells, but not of normal cells. An exogenously 
added molecule specific for PS, such as Annexin V-FITC, will bind to PS on the outer membrane of 
apoptotic cells, but cannot react with the PS of normal cells (Adapted from [130]). 
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1.8.4. Apoptosis measurement 
 
Since apoptosis has so many characteristic changes that appeared this type of cell death, 
those changes have become markers that are used to identify this mode of cell death by 
several laboratory methods [128]. 
There are several commercial kits available to detect and count apoptotic cells and since 
many features of apoptosis and necrosis can overlap, it is crucial to employ two or more 
distinct assays to confirm that cell death is occurring via apoptosis. The assays should 
be based on a different principle in order to have a more complete approach. Other 
methodology for apoptosis detection that is becoming very popular is the multiplex, in 
which the same sample allows to gather more than one set of data [126]. 
Therefore, there are apoptosis assays based on several methodologies, such as 
cytomorphological alterations; DNA fragmentation; detection of caspases, cleaved 
substrates, regulators and inhibitors; membrane alterations; detection of apoptosis in 
whole mounts and mitochondrial assays [126]. 
All assays have advantages and disadvantages regarding the object of study. 
Consequently, it is crucial to understand the pros and cons of each assay and to define 
the best combination of assays to allow a more complete and accurate study [126]. 
 
1.9. Research objectives 
 
The molecular mechanisms by which Lp kills protozoan host cells are largely unknown. 
In 1998, Hagele et al have demonstrated that Lp is able to induce apoptosis in human 
monocytes and that this process depends on the multiplicity of infection (MOI), i.e. the 
proportion between Lp and the host, and the time post-infection. However, by studying 
infection in Ac at 24h post-infection and a MOI of 50, they concluded that Lp was not 
able to induce apoptosis in Ac. This finding suggested that Lp induces different 
mechanisms of cell killing to evade the main hosts: protozoan and human cells [121]. 
More recently, Gao and Kwaik demonstrated that intracellular Lp kills and exits 
Acanthamoeba polyphaga preferentially by induction of necrosis. They have also 
confirmed that, as in the mammalian cells, PS is distributed in the inner leaflet of the 
plasma membrane in Acanthamoeba and that specifically Acanthamoeba polyphaga 
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possesses a functional apoptotic pathway [133]. 
The main objective of this study was to clarify if Lp is able to induce apoptosis in the 
natural host Ac.  
Since the molecular mechanisms by which Lp kills protozoan host cells remains 
uncertain and the published studies were based only in a few conditions of the infection, 
we proposed to clarify whether Lp induces apoptosis in Ac, using different MOIs and 
time post-infection. 
The apoptosis detection in Ac was assessed by membrane alterations (PS 
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Chapter 2. Material and Methods 
 
All the experimental procedures were performed in a tissue culture room, in a Class II 
Type A2 Biological Safety Cabinet that maintained the sterility of cell lines and 
protected both the user and the experiment. In the tissue culture room, an exclusive 
disposable lab coat was always used, proper aseptic techniques were assembled in order 
to eliminate possible contaminants and all the materials were disposable plastic. 
 
2.1. Microorganisms, culture media and growth conditions 
 
In this study, we used Lp strain Paris (Lp Paris), isolated from patients and the 
environment in the area of Paris, France, from 1987 to 1997 (courtesy of the Pasteur 
Institute) and a line of Acanthamoeba castellanii (Ac) strain Neff (ATCC® 30010™). 
A stock culture of both strains was preserved at -80ºC. Lp was stored in skim milk and 
Ac was stored in 10% DMSO + 90% FCS. 
 
2.1.1. Growth of Legionella pneumophila strain Paris 
After thawing, Lp Paris was cultured on Buffered Charcoal Yeast Extract (BCYE, 
Appendix 2) agar supplemented with ACES Buffer/potassium hydroxide, ferric 
pyrophosphate, L-cysteine HCl and α-ketoglutarate (Legionella BCYE Growth 
Supplement SR0110A, Oxoid), and incubated at 37°C, for 48h. 
 
2.1.2. Growth of Acanthamoeba castellanii 
Ac was grown in axenic static culture in culture T-flasks with a surface area of 25cm2, 
in 6ml of Peptone-Yeast Extract-Glucose medium (PYG, Appendix 3) at room 
temperature.
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Additionally, to ensure that the cultures remained viable for an extended period of time, 
we had to follow some procedures that will be described below: 
 Monitor the culture regularly, to confirm its viability and healthy morphology, 
using an inverted microscope (Meiji Techno, TC-5300). 
 When the culture reaches the peak density, i.e., confluent layer of Ac on the 
bottom surface of the flask, the culture was split to a new culture flask. In order 
to do this, first, the confluent layer of Ac was washed with 3ml of PYG, for three 
times, to assure that the wastes resulting from metabolism and unviable Ac were 
rejected. After this, the Ac were harvested in 3ml of PYG with a cell scrapper 
and approximately 0.25ml of the Ac suspension was transferred to a new flask. 
Repeat the procedure in 2-3 days intervals. 
 Prepare fresh PYG on a monthly basis in order to maintain this procedure. 
 
2.2. Infection Protocol of Acanthamoeba castellanii with Legionella 
pneumophila strain Paris 
 
For the infection protocol of Ac with Lp Paris, both microorganisms required previous 
growth conditions and specific procedures before the infection. The preparation of each 
microorganism for infection will be described below. 
 
2.2.1. Preparation of Legionella pneumophila strain Paris liquid culture for 
infection 
For each infection, three to four colonies from a new 48h passage culture in BCYE agar, 
were cultured to 100ml of ACES-buffered yeast extract broth (AYE, Appendix 4) and 
incubated at 37ºC with shaking at 170 rpm (incubator I10-C+ACOP. E, OVAN). To 
monitor the growth of the liquid culture we used a spectrophotometer (Shimadzu, UV-
1700 PharmaSpec) to measure the optical density at 600nm (OD600), at hourly intervals. 
These measures were used to build the Lp Paris growth curve and determine when the 
culture reached the beginning of the stationary phase, i.e. when the difference between 
two consecutive measures was 0.05 (previously determined by the research group).  
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Once the culture was in the stationary phase, 5ml of the suspension were collected to a 
15ml sterile Falcon tube and centrifuged (centrifuge ROTINA 380R, Hettich) for 15 
minutes at 3095 x g. The supernatant was discarded and the pellet was resuspended in 
10ml of Minimum Medium (MM, Appendix 5). The OD600 of the suspension was 
measured and adjusted to 1.2, which represents a concentration of 109 CFU/ml 















2.2.2. Preparation of the Acanthamoeba castellanii confluent layer for 
infection 
For each infection, we used a confluent layer of Ac with 48h of growth. The Ac 







Figure 11 – The Lp Paris liquid culture in the stationary phase was collected (A) and centrifuged for 
15 minutes at 3095 x g (B). For the infection, the concentration of Lp Paris was measured by 
spectrophotometry (C). 
Figure 10 – Lp Paris was inoculated, in duplicate, on AYE (A) and incubated at 37ºC, 170 rpm (B). The 
Lp Paris growth was monitored by measure of OD600 until the culture reached the stationary phase (C). 
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(B) (A) 
times. To detach the Ac from the bottom layer of the flask, we used a cell scrapper and 
1,5ml of MM. A counting chamber (Thoma, 0.1mm) was used in order to count the Ac 
(Transmitted Light Microscope Standard 25 ICS, Carl Zeiss) and determine the 














2.2.3. Infection of Acanthamoeba castellanii with Legionella pneumophila 
strain Paris 
For the infection protocol, we tested three different MOIs: 10, 50 and 100 (this values 
were previously established by the research group). In each infection, we prepared the 
required culture T-flasks with an Ac monolayer of 3x106 Ac/ml. After this, we 
calculated the required volume of the Lp Paris suspension to infect the Ac (considering 
the intended MOI). Once the Lp Paris was pipetted into each flask, the flasks were 
incubated at 37ºC for one hour. After the incubation time, we washed each flask with 
3ml of MM, for three times, to remove the extracellular Lp. After the washing process, 
we added a final volume of 6ml of MM and the flasks were incubated at 37ºC. The 
infection is considered to be started at this point. 
Each infection assay had a negative control (flask with uninfected Ac in MM, incubated 
at 37ºC). 
 
2.3. Apoptosis analysis 
 
The apoptosis analysis was performed using two techniques: flow cytometry and 
Figure 12 – The Ac concentration for infection was determined by counting on a Thoma Chamber with a 
transmitted light microscope (A) at 10x (B). 
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agarose gel electrophoresis. In this study, we analyzed the Ac at different time post- 
infection: 8, 12, 14, 16, 18, 20 and 24 hours. Each assay had a negative control (the 
same referred in 2.2.3) and a positive control. The positive control chosen for Ac 
apoptosis was heat shock and had to be optimized. To optimize the positive control, we 
tested different incubation time (1, 2.5, 3.5, 4, 4.5, 5 and 5.5 minutes) at 56ºC followed 
by one hour at 37 ºC and analyzed using three techniques: agarose gel electrophoresis, 
fluorescent microscopy and flow cytometry. 
 
2.3.1. Flow cytometry 
Flow cytometry is a biophysical technology that allows a rapid analysis of both 
qualitative and quantitative characteristics of single cells. Those characteristics include 
cell size, cytoplasmic complexity, DNA or RNA content, and a wide range of 
membrane-bound and intracellular proteins [134]. 
In this method, cells are fluorescently labelled and then flow in front of a laser which 
will excite them to emit light at varying wavelengths. By measuring the emitted 
fluorescence, it is possible to determine the amount and type of cells present in a 
sample [135]. 
 
2.3.1.1.    Staining of Acanthamoeba castellanii with Annexin V-FITC 
and 7-AAD 
As referred in the Introduction chapter (1.8.3), one of the biochemical features of the 
apoptotic process is the expression of cell surface markers in the outer leaflet of the cell 
membrane, such as PS. By flow cytometry, we can detect the apoptotic cells by the 
binding of the externalized PS with the highly fluorescent Annexin V. In this study we 
used Annexin V-FITC, a member of the annexin family of intracellular proteins that 
binds to PS in a calcium-dependent manner. 
Although it will not bind to normal living cells, Annexin V-FITC will bind to the PS 
exposed on the surface of apoptotic cells. Thus, Annexin V-FITC has proved suitable 
for detecting apoptotic cells, for instance by multicolor flow cytometry or fluorescence 
microscopy. Additionally, since necrotic cells are labeled upon rupture of their plasma 
membrane, it is important to control the membrane integrity of the PS-positive cells by 
double-staining with membrane-impermeable DNA dyes such as 7-AAD. In these 
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assays, healthy cells are doubly negative to Annexin V-FITC and 7-AAD, whereas cells 
in the early phases of apoptosis are Annexin V-FITC-positive but 7-AAD-negative, and 
secondary necrotic cells are doubly positive to Annexin V-FITC and 7-AAD [130]. 
For the staining of Ac with Annexin V-FITC and 7-AAD we used the following 
protocol (previously established by the research group): 
1. Harvest the Ac of each condition (the infected Ac of each hour post-infection, 
the corresponding negative control and the positive control). 
2. Centrifuge the tubes for 5 minutes at 2000 x g. 
3. Discard the supernatants and wash the pellets in 1ml of PBS (1x). 
4. Divide the total volume into two Eppendorf tubes (stained and unstained). 
5. Centrifuge the tubes for 5 minutes at 2000 x g. 
6. Discard the supernatants and resuspend the pellets in 190µl of PBS + Ca2+, 
5µl of Annexin V-FITC (ImmunoTools) and 5µl of 7-AAD (SIGMA) - for 
the stained tubes - and 200µl de PBS + Ca2+ - for the unstained tubes. 
7. Incubate the tubes for 15 minutes in the dark, at room temperature. 
8. After the incubation period add 800µl of PBS (1x) to each tube. 
 
After the staining protocol, the Ac were analyzed in a 3-laser 9-color flow cytometry 
analyzer (CyAn ADP, Beckman Coulter). 
 
2.3.1.2. Strategy to analyze flow cytometry results 
For the analysis, the Ac were distributed in four groups considering the detected 
fluorescence: live, early apoptotic, late apoptotic and necrotic. 
 
Table 1 - Distinguishing apoptosis from necrosis using Annexin V-FITC and 7-AAD staining. 
 Live Early Apoptotic Late Apoptotic 
Necrotic 
Annexin V-FITC staining - + + 
- 
7-AAD staining - - + 
+ 
 
These four groups were delimited by four gates, created based on acquisition of positive 
control cells that were single staining (with Annexin V-FITC only or 7-AAD only) and 
considering characteristics such as the fluorescence intensity, the cell size and 
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granularity (Figure 13).  
The Ac that were Annexin V-FITC positive were considered the early apoptotic cells 
and the Ac that were 7-AAD positive were considered the necrotic cells. For this 




2.3.1.3  Statistical analysis 
The flow cytometry results were statistically analyzed using the software GraphPad 
Prism® 6 (version 6.01). A Student t test analysis was done in order to compare each 
sample with the negative control (paired samples). We considered P values < 0,05 
statistically significant (* P < 0,05; ** P < 0,01 and *** P < 0,001). 
 
2.3.2. Agarose gel electrophoresis to assess DNA fragmentation 
As referred in the Introduction chapter (1.8.1), one characteristic feature of apoptosis is 
the activation of endonuclease(s) that preferentially cleave DNA at the internucleosomal 
sections. As a result, the products of DNA degradation are nucleosomal and 
oligonucleosomal DNA sections (with approximately 180 base pairs) that generate a 
characteristic ‘‘ladder’’ pattern that is possible to identify during an agarose gel 
electrophoresis [128].   
Therefore, after the extraction of DNA from a lysed cell homogenate we performed an 
agarose gel electrophoresis to visualize whether endonuclease cleavage products, 
Figure 13 – Definition of the gates according to the emitted fluorescence. (A) Positive control - Ac 
treated with heatshock, single stained with 7-AAD; (B) Positive control - Ac treated with heatshock, 
single stained with Annexin V-FITC. 
A B 
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characteristic from apoptosis, were formed. 
For this technique, we compared three different DNAs: Lp, Ac from the negative and 
positive control and infected Ac. 
Lp Paris DNA was extracted using the InstaGeneTM Matrix (Bio-Rad) and Ac DNA was 
extracted using the QIAamp® DNA Mini Kit (QIAGEN). 
 
2.3.2.1.  Agarose gel electrophoresis 
DNA fragments were separated via agarose gel electrophoresis (1.5%). The gels were 
prepared by dissolving the agarose in TBE buffer (0.5x). To visualize the DNA, 2 µl of 
(10 mg/ml) ethidium bromide (BioRad) was added to the agarose solution. To load the 
samples, 5µl of DNA was mixed with 2µl of the agarose gel loading buffer. 
Electrophoresis was performed for 40 minutes at 140 V (Horizon 58, Life 
Technologies). The DNA was detected using UV light linked to photographic system 
(Kodak EDAS 290) and the size of the DNA was determined using 1Kb DNA ladder 
(InvitrogenTM). 
 
2.4.   Analysis of the intracellular Legionella pneumophila strain Paris 
replication 
 
To measure the entry and survival of Lp Paris in Ac, we performed an infection assay 
with a MOI of 100 for 24 hours at 37ºC. After, we plated the initial Lp suspension (0h) 
and the intracellular Lp (obtained from the Ac monolayers lysis, Appendix 6) from 1 
and 24 hours post-infection into BCYE agar plates in order to determine the CFU/ml of 
Lp from each time point.  
The distribution of the bacteria in the plates was made by spread and drop plate method. 
 
2.4.1. Spread and drop plate method 
For bacterial enumeration by spread and drop plate method, successive dilutions of Lp 
(from each hour of infection) were pipetted into BCYE agar plates. For the spread 
method, we pipetted 100µl of each dilution to a specific plate. For the drop method, all 
plates were divided in quadrants (four dilutions each) and two different volumes of drop 
were tested: 10 and 30µl. For the spread method duplicates of each dilution were made 
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while for the drop method were made triplicates of each dilution.  
After the drops on the agar dried, the petri plates were inverted and incubated at 37ºC 
until colonies were formed for counting. 
 
2.4.2. Counting and CFU calculation 
After appropriate incubation (approximately four days) the plates were inspected and 
the colonies of each dilution were counted. To calculate the CFUs/ml we considered the 
dilutions with 30 to 300 CFUs/plate - for the spread method - and the dilutions with 3 to 
30 CFUs/drop - for the drop method. 
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Chapter 3. Results 
 
3.1. Study of the death mechanisms induced by Legionella pneumophila in 
Acanthamoeba castellanii 
 
There are several factors that can affect the timeline of biochemical events associated 
with cellular death. Therefore, in order to clarify which death mechanisms are inducted 
by Lp Paris in Ac we evaluated the following conditions: 
 
3.1.1. Legionella pneumophila strain Paris culture for infection 
For the infection protocol, we were interested in having Lp Paris from the stationary 
phase.  
In order to determine when the cultures reached this phase, we monitored the growth of 
the all cultures by spectrophotometry and built a growth curve. 
 
Table 2 – OD600nm measures of Lp Paris in AYE.  
Incubation hours 
OD600nm 
1 2 3 
0.5 0.156 0.043 0.112 
1.5 0.279 0.193 0.200 
3.5 0.372 0.323 0.308 
5.5 0.556 0.608 0.523 
6.5 0.702 0.835 0.699 
7.5 0.903 1.137 1.040 
8.5 1.235 1.418 1.287 
9.5 1.507 1.533 1.509 
10.5 1.579 1.565 1.573 
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We observed that Lp Paris in AYE would usually take up to 10 hours to reach the 

















To infect the Ac with stationary phase-Lp Paris culture and then evaluate the 
experiments regarding the earlier hours post-infection, we opted to grow Lp Paris for 
24h in BCYE agar plate, due to practical reasons. Nevertheless, we first verified that 
growing Lp Paris either in liquid medium or agar plates gives rise to the same results, 
concerning the infection process. 
 
3.1.2. Optimization of the positive control for apoptosis 
After submitting the Ac to heat shock (treated Ac), DNA from each time point was 
purified and analyzed through agarose gel electrophoresis (1.5%). By this technique, we 
were able to detect the presence of endonuclease cleavage products characteristic from 
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Then, we performed the double staining of the treated Ac with Annexin V-FITC and 7-
AAD in order to analyze by fluorescent microscopy and flow cytometry.  
By fluorescent microscopy, we verified a difference between the negative control 
(untreated Ac) and treated Ac (1, 2.5, 3.5, 4, 4.5, 5 and 5.5 minutes at 56ºC). In the 
negative control, we only observed unspecific fluorescence around the Ac membrane 
(yellow fluorescence, Figure 16 A), related to the Ac autofluorescence. In the treated Ac, 
we observed green fluorescence (Figure 16 B) around the Ac membrane as a result of 
the binding of the Annexin V-FITC with the externalized PS in the surface of the treated 
Ac. This result showed that treated Ac are able to externalize PS to the membrane 
surface, which is one of the membrane alterations that occurs during the apoptotic 
process.  
Moreover, we observed red fluorescence in the center of the cell, meaning that the 7-
AAD was able to bind with the DNA of the Ac. This assay validated the use of Annexin 
V-FITC and 7-AAD for the purpose of our study. 
 
 
  1       2        3      4       5       6       7 
Figure 15 – Agarose gel electrophoresis (1.5%). (1) 1 kb DNA Ladder; (2) Ac treated for 3.5 minutes; 
(3) Ac treated for 4 minutes; (4) Ac treated for 4.5 minutes; (5) Ac treated for 5 minutes; (6) Ac treated 
for 5.5 minutes; (7) Negative control (untreated Ac). 
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By flow cytometry, we obtained the percentages of untreated and treated (1, 2.5, 4 and 5 
min of incubation at 56ºC) Ac in each stage (live/encysted, early apoptotic, late 
apoptotic and necrotic). The obtained results are presented in Table 3. 
 
Table 3 – Apoptosis detection by flow cytometry after heat shock with different times at 56ºC. The 
results are presented in percentages. 
 Untreated Ac 
Treated Ac 
1 minute 2.5 minutes 5 minutes 
Live/Encysted 86.45 68.43 1.21 0.87 
Early Apoptotic 0.01 3.5 27.5 58.2 
Late Apoptotic 0.32 14.8 70.3 40.7 
Necrotic 13.22 13.27 0.99 0.23 
 
Considering these results, we concluded that heat shock was a good positive control for 
Ac apoptosis and that the best protocol was incubation for 5 minutes at 56ºC followed 
by 1 hour incubation at 37ºC. 
 
3.1.3. Different conditions of infection  
As referred in 1.9, in order to clarify the cell death process that occurs in Ac after 
infection with Lp Paris, we performed the infection protocol considering different times 
post-infection and MOI values. Following the infection protocol, Ac were double 
Figure 16 – Fluorescent microscopy analysis of Ac double stained with Annexin V-FITC and 7-AAD. 
(A) Normal Ac; (B) Ac submitted to heat shock at 56ºC for 5 minutes. 
A B 
A B 
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stained with Annexin V-FITC and 7-AAD and analyzed by flow cytometry to divide the 
infected Ac population in four main groups considering their viability: live/encysted, 
early apoptotic, late apoptotic and necrotic. This way, we were able to understand the 
different stages that infected Ac went through during infection and how the time post-
infection and MOI values would influence those stages. 
In each assay, the infected Ac were compared with a negative control (uninfected Ac, as 
described in 2.2.3) in order to validate that the obtained results were a consequence of 
the infection by Lp Paris. In order to ease reading, since the obtained values for the 
negative control were very similar in all experiments, the means of the percentages from 











The first infection assay was performed with two different MOI values (10 and 25) and 











 Figure 18 – Flow cytometry analysis of the Ac death mechanism inducted by Lp Paris at 20 hours post-
infection. 
MOI 10 
Figure 17 - Means of the obtained percentages from each stage (live/encysted, early apoptotic, late 
apoptotic and necrotic) of the uninfected Ac (negative control), from all the infection assays. 
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Figure 20 - Flow cytometry analysis of the Ac death mechanism inducted by Lp Paris: (A) at 18.5 h post-





These results showed a higher percentage of apoptotic Ac (26% vs 18%) when the 
infection was performed with a MOI of 10. Compared with the negative control (Figure 
17), here we observed an increase of 10 fold in the percentage of apoptotic Ac (Figure 
18). 
After this infection assay, we maintained the MOI of 10 and analyzed the infected Ac at 
18, 20 and 23 hours post-infection in order to understand the progression of the death 










The obtained results revealed a higher percentage of apoptotic Ac (20%) at 23 hours 
post-infection. However, this percentage was higher for the late apoptotic stage, 
meaning that at this time point the infected Ac were already at the end of the apoptotic 
process. 
We were able to conclude that with lower MOI values, the infected Ac reach the final 
stages of apoptosis at the latest hours post-infection.  
In the following infection, we were interested in analyzing the effect of higher MOI 
values on the infected Ac. Therefore, we analyzed the 18.5, 20 and 21.5 hours post-
















































Figure 19 - Flow cytometry analysis of the Ac death mechanism inducted by Lp Paris: (A) at 18h post-
infection; (B) 20h and (C) 23h. 
B 
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The obtained results showed a decrease in the apoptotic Ac between the 18.5 and 21.5 
hours post infection. Therefore, we concluded that between those hours the infected Ac 
are already reaching the final stages of their death process. 
Since we wanted to clarify if Lp Paris induces apoptosis in Ac, we decided to analyze 
the infected Ac at the earlier hours post-infection in order to understand when the 
induction process begins and determine the percentage of infected Ac that undergoes 
apoptosis at that time point. Therefore, we choose to focus our analysis in the infected 









Compared with the negative control (Figure 17), here we observed an increase of seven-
fold in the percentage of apoptotic Ac (Figure 21). Moreover, this assay showed similar 
percentages between early and late apoptotic Ac and had the lowest percentage of 
necrotic Ac, indicating that apoptotic process must be induced before this time point.  
While we performed the infection assays, we noticed that the infected Ac suffered 
several morphological changes during the infection course. One of those morphological 
changes was the loss of their adherence, and in the same flask we would have the total 
population of Ac separated in two subpopulations: one at the bottom of the flask and 
another one in suspension. This separation could indicate that the death pathway of Ac 
had been activated. So, we performed several infection protocols in order to determine 
the time post-infection when this change would begin. Figure 22 shows the infected Ac 




Figure 21 - Flow cytometry analysis of the Ac death mechanism inducted by Lp Paris at 12h post-
infection, with a MOI of 100. 
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Figure 23 - Flow cytometry analysis of the Ac death mechanism inducted by Lp Paris at 8h (total 
population). (A) We can observe by the graphic (FSC vs SSC) that the total population has two 










With the microscopic observations, we verified that at a MOI of 100, the Ac began to 
lose their adherence around 8 hours post-infection. 
Acknowledging the previous microscopic observations, we performed an assay where 
we analyzed the Ac after 8 hours post-infection with a MOI 100. In this assay, we 
analyzed, separately, the total Ac population (amoebic shape Ac) (Figure 23) and the 












However, according to the graphic that gives the morphological parameters - size (FSC) 
vs internal complexity (SSC) - of the infected Ac, we realized that we could divide the 
total population in two subpopulations (Figure 24). 
Figure 22 – Light microscopic images of the infected Ac, 3 hours post-infection, with three different MOI 








A B C 
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With these results, we verified that the first subpopulation (A) gathered the major part 
of apoptotic Ac, while the second subpopulation (B) was made of Ac that were still in 
the beginning of their apoptotic process.  
Although the Ac were all infected at the same time, it is possible that some differences 
occurred considering the timing when Lp Paris induces the death of the Ac. In the total 
population, we can see Ac with different sizes and internal complexity. 
When we analyzed the suspended Ac population alone, we verified a higher percentage 



















Figure 24 - Flow cytometry analysis of the two sub-populations, separately. A and B represent the first 









Figure 25 - Flow cytometry analysis of the suspended Ac population at 8h post-infection. 
A B 
C D 
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All the previous analyses were performed using Attune® Acoustic Focusing Cytometer 
(Applied Biosystems). However, due to technical reasons (unavailable flow cytometer), 
we had to continue our study in a different flow cytometer, the CyAn™ ADP Analyzer 
(Beckman Coulter) at IGC (Instituto Gulbenkian de Ciência). 
For the first assay in this new cytometer, we kept the previous conditions for the 
infection protocol (infected Ac at 8 hours post-infection with a MOI 100). The obtained 
results are shown in Table 4. 
 
Table 4 - First flow cytometry analysis of the infected Ac with MOI 100 at 8h post-infection, in the 











Negative Control 73.08 5.03 10.7 7.17 
Total 43.22 14.25 31.77 5.98 
Suspension 37.94 9.59 45.34 4.4 
 
According to these results, 46.02% of the total population of Ac are apoptotic (14.25% 
Early Apoptotic + 31.77% Late Apoptotic), opposing with the negative control where 
only 15.73% of the total population of Ac is in that stage (5.03% + 10.7%).  
In order to verify if the activation of the apoptotic process in the Ac is in fact induced by 
Lp Paris, we carried out triplicates of this assay. The results are summarized in Table 5. 
The negative control included the total population of uninfected Ac in order to validate 
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Negative Control 84,41 1,22 3,63 8,39 
Total 54,85 12,08 21,66 6,28 
Suspension 58,49 8,67 23,75 5,05 
3º 
Negative Control 79,87 5,34 5,85 4,92 
Total 39,29 17,79 34,07 3,71 
Suspension 56,31 15,71 18,96 5,53 
4º 
Negative Control 87,48 2,16 3,18 4,16 
Total 58,23 15,05 18,33 4,86 
Suspension 70,16 6,38 16,77 3,34 
 
The triplicates were statistically analyzed, considering a Student's t-test distribution, in 
order to determine if the differences between the negative control (uninfected Ac) and 
the infected Ac were statistically significant.  
The statistical analysis showed significant differences in the percentage of live/encysted 
and apoptotic Ac between the negative control and the infected Ac, whether considering 
the total population (Figure 26) or the suspended subpopulation (Figure 27).  
According to these results we can conclude that the apoptotic process detected in the Ac 
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Figure 26 - Graphic where the Ac from the negative control are compared with the total population of 
infected Ac. Results from the triplicates are represented in percentages, and statistical differences (*, P < 
0,05; ** P < 0,01 and *** P < 0,001) are shown, referring to the difference between live, early apoptotic, 


















Figure 27 - Graphic where Ac from the negative control are compared with the suspended subpopulation 
of infected Ac. Results from the triplicates are represented in percentages, and statistical differences (*, P 
< 0,05; ** P < 0,01 and *** P < 0,001) are shown, referring to the difference between live, early 
apoptotic, late apoptotic and necrotic Ac after infection with Lp Paris and the negative control. 
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3.1.4. Detection of apoptosis using agarose gel electrophoresis 
After the analyses by flow cytometer, DNA of the infected Ac after 8 hours post-
infection with a MOI of 100 was purified and analyzed through agarose gel 
electrophoresis, as a complement assay for apoptosis detection. For this analysis were 
also considered the DNA from Lp, negative control and Ac alone. The obtained results 






















By this technique, we were not able to detect the presence of endonuclease cleavage 
products characteristic from apoptosis in the infected Ac. With this result, we concluded 





Figure 28 - Agarose gel electrophoresis (1.5%). (1) 1 kb DNA Ladder; (2) Lp Paris; (3) Untreated Ac; 
(4) Positive control (heat shock); (5) Uninfected Ac; (6) Infected Ac (8h, MOI 100). 
 
1           2            3          4          5      6 
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3.2. Intracellular replication of Legionella pneumophila strain Paris 
 
After infection, Lp Paris replicates within the Ac and then evades the host 
(approximately 24h post-infection). In order to determine the intracellular replication 
rate of Lp Paris in Ac, we plated different dilutions of Lp Paris suspensions obtained 
from lysed Ac at two different hours post-infection (1 and 24h). 
 
3.2.1. Validation of the drop plate method for bacteria enumeration 
For the determination of the intracellular replication of Lp Paris, we had to compare the 
accuracy and fidelity of drop plate method vs spread plate method, the “gold standard” 
method for enumerating bacteria. For this comparison, we plated the Lp Paris from 
infected Ac at different hours post-infection with both methods. 
Each dilution was plated in duplicate and for the drop method two different volumes of 
drop were tested: 10 and 30µl. After plating, the petri plates were incubated at 37ºC 
until colonies were formed for counting (approximately 4 days). To calculate the 
CFUs/ml we considered the dilutions with 30 to 300 CFUs/plate - for the spread method 
- and the dilutions with 3 to 30 CFUs/drop - for the drop method. After calculation of 
the CFUs/ml for each method, we obtained the results are presented in Table 6. 
 
Table 6 – Calculation of CFU/ml of spread and drop plate methods. 
Post-infection (h) Dilution Method CFUs/ml 
0 10-9 
Spread 2.1*1012 
Drop 10µl 2.0*1012 
Drop 30µl 1.2*1012 
1 10-3 
Spread 1.4*106 
Drop 10µl 1.7*106 
Drop 30µl 1.1*106 
24 10-6 
Spread 2.05*109 
Drop 10µl 1.6*109 
Drop 30µl 0.44*109 
 
The results of the drop plate method were similar to the results of the spread method. 
Considering these results, we chose to use the drop plate method for bacteria 
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enumeration instead of the spread method. We also standardized our plating protocol to 
drops with a volume of 30µl. Examples of both plating methods are shown in Figures 


























3.2.2. Determination of the intracellular replication rate of Legionella 
pneumophila strain Paris 
To determine the intracellular replication rate of Lp Paris in Ac, we plated the initial Lp 
suspension (0h) and intracellular Lp from two different hours post-infection (1 and 24 






Figure 29 – Example of plates with the drop plate method. Two BCYE agar plates with different 
dilutions (specified in each quadrant) of the Lp Paris liquid culture by the drop plate method with drops 





Figure 30 - Example of a plate with the spread method. A BCYE agar plate with a dilution of -10 of 
the Lp Paris liquid culture by the spread method (photo obtained in the present study). 
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Table 7 – Drop plate of initial suspension (0h) and 1 and 24 hours post-infection 
Post-infection (h) Dilution CFUs/ml 
0 10-8 1.6*1010 
1 10-3 3.5*105 
24 10-8 7.5*1010 
 
The percentage of infectious bacteria was calculated by the following equation: 
 
Ratio of infectivity = (intracellular Lp Paris at 1h) x 100 
                                    (Lp Paris added at 0h) 
 
Ratio of infectivity = 0.002% 
 
The relative number of CFU/ml of Lp at 1 and 24 hours post-infection was calculated by 
dividing the CFU at each time point by the CFU at the first time point. 
The yield of CFU for Lp Paris increased approximately 105-fold during a 24h infection. 
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Chapter 4. Discussion and Conclusions 
 
It has been suggested that the infectious particle for Legionnaires’ disease is an amoeba 
infected with Lp [6]. Initially it was believed that the Lp transmission occurred by 
inhalation of the free-living bacteria but several authors have been verifying that the 
transmission is made by inhalation of MIFs (mature intracellular form) [96, 11]. 
Has been said trough this dissertation, the interaction between Lp and free-living 
amoebae shows several similarities with the one that occurs during infection of human 
alveolar macrophages by Lp. Although the interaction between Lp and mammalian cells 
have already been studied in great detail, the processes that are involved in interaction 
between Lp and prokaryotes hosts such as amoebae has rarely been addressed. One of 
those processes is the death mechanism induced by Lp in order to evade the amoeba and 
begin a new infection cycle. 
Kwaik et al [133] have shown that at a MOI of 0.5, 5, or 50, Lp induces apoptosis in 
macrophages and alveolar epithelial cells within a few hours of infection in a dose-
dependent manner. Later on, the group examined the molecular mechanisms by which 
Lp kills the protozoan host Acanthamoeba polyphaga (Ap) and demonstrated that Ap 
undergoes apoptosis upon induction by actinomycin D (an apoptosis inducer used has a 
positive control) but, unlike in mammalian cells, Lp does not induce apoptosis in this 
protozoan host. Despite the ability of Ap to undergo apoptosis, intracellular surface 
exposure of PS has a result of Lp infection did not occur. In addition, the group showed 
that intracellular Lp kills Ap preferentially by the induction of necrosis. Additionally, 
we noticed that among these studies, few infection conditions parameters such as MOI 
and time post-infection of the analyzed protozoan, were considered. In some cases the 
analyses were made considering only one MOI value to infect the protozoan or only one 
time point post-infection was analyzed. 
Considering that the published literature on the evasion process of Lp from Ac is very 
limited and vague, in this study we wanted to clarify this question by analyzing the 
infection process of Lp in Ac, considering different conditions from the ones that have 
already been studied. 
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Since the ability to undergo apoptosis of the protozoan Ap has been demonstrated and 
that in mammalian cells Lp has been shown to induce apoptosis, we had to start our 
study by analyzing the Ac ability to undergo apoptosis. This study was performed based 
on two biochemical processes that may occur during apoptosis: DNA fragmentation and 
intracellular surface exposure of PS. To induce the apoptotic process we used heat 
shock as a positive control. 
The DNA fragmentation process was verified by agarose gel electrophoresis which is a 
good methodology since is easy to perform, has a sensitivity of 1×106 cells and is useful 
for tissues and cell cultures with high numbers of apoptotic cells per tissue mass or 
volume, respectively. By this technique, we were able to visualize the systematic 
cleavage of DNA into oligonucleosomal multimers of 180-200 bp, which is considered 
the "hallmark" of apoptosis [126]. With these results we were able to conclude that 
DNA fragmentation is one of features that occur when Ac undergoes apoptosis when 
submitted to heat shock.  
Moreover we wanted to verify if the Ac were able to externalize the PS located in the 
inner membrane when undergoing apoptosis. Under normal physiologic conditions, PS 
is predominantly located in the inner leaflet or cytosol-facing part of the plasma 
membrane. Upon initiation of apoptosis, PS loses its asymmetric distribution in the 
phospholipid bilayer and is translocated to the extracellular membrane leaflet where it 
identifies cells as targets for phagocytosis [136]. We visualized this feature by 
fluorescent microscopy and flow cytometry. By fluorescent microscopy we were able to 
visualize the difference between the fluorescence emitted by the negative control (Ac in 
normal conditions) and the Ac submitted to heat shock. For the negative control, we 
only visualized unspecific fluorescence, resulting from the Ac autofluorescence. The Ac 
submitted to heat shock, revealed green fluorescence, which is known to be the result of 
the binding between the recombinant Annexin V conjugated to green-fluorescent FITC 
dye (Annexin V-FITC) and the PS present in the surface of the Ac. After, this result was 
confirmed by flow cytometry where the higher percentage of cell death corresponded to 
apoptotic Ac, opposing to the percentage of necrotic ones. These assays combined 
showed that Ac are able to externalize the PS located in the inner membrane when 
undergoing apoptosis. 
In conclusion, our results indicate that DNA fragmentation and externalization of PS to 
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the outer leaflet of the cell membrane, which are characteristic processes observed 
during apoptotic death in eukaryotes, can be identified in the process of heat-induced 
cell death in Ac. 
After verifying the Ac ability to undergo apoptosis, we were able to begin to study the 
death mechanism that was induced by Lp during the evasion from Ac. Our analyses 
were made by flow cytometry and agarose gel electrophoresis. 
Compared to the alternative methods (e.g. analysis of cell morphology, DNA gel 
electrophoresis) flow cytometry is rapid, objective, and very sensitive. However, 
improper use of flow cytometry in analysis of cell death and in data interpretation is 
possible and it is due to some errors like misclassification of nuclear fragments and 
individual apoptotic bodies as single apoptotic cells or assumption that the apoptotic 
index represents the rate of cell death [128]. Because of the lack of previous studies of 
Ac death mechanism using flow cytometry, in our initial analyses we had to adapt a 
protocol that allowed us to analyze this kind of cells. Everything had to be tested several 
times before we reached an ideal protocol for flow cytometry analysis and data 
interpretation. Several alterations to the infection protocol conditions were also tested, 
in order to determine the ideal value of MOI and the time post-infection that would 
allow us to study the death process activated on Ac infected by Lp. 
In our first assays, we assumed that the activation of the death mechanism of Ac by Lp 
would occur near the timing when Lp evaded the Ac (approximately 24 hours post-
infection). However, by that time, a great part of the infected Ac had already reached the 
final stage of their death process, losing all their integrity and ability to bind with the 
Annexin V-FITC or the 7-AAD. After this conclusion, we had to start analyzing the 
previous hours post-infection. 
By microscopic observation, we verified that at 8 hours post-infection, with a MOI of 
100, the infected Ac start to change their amoebic morphology and begin to appear the 
first Ac suspended in the medium. These observations lead us to believe that these 
alterations are somehow linked to the moment when Lp induces the death of Ac in order 
to evade. This hypothesis would also imply that induction of the Ac death is done hours 
before the Lp evades Ac, contrary to our first hypothesis that the Lp evasion from Ac 
would only occur when Lp was already in the virulent stage and ready to begin a new 
infection cycle. 
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By flow cytometry analysis of the infected Ac in the conditions (8 hours post-infection 
with a MOI of 100), our results showed that in fact, in these conditions, almost 50% of 
the infected Ac were apoptotic, opposing to the negative control where only about 15% 
were apoptotic. After performing triplicates of this assay we were able verify by 
statistical analysis that there were in fact significant differences between the negative 
control and the infected Ac regarding the apoptotic Ac and the ones that were live or 
encysted.  
In 1998, Hägele et al [121] verified that Lp did not induce apoptosis in the protozoan 
host Ac. However, in that study only the 3, 5 and 24 hours post-infection were 
considered, the infection was performed only with a MOI of 50 and only 10000 cells 
were analyzed. Additionally, some questions remained at the end of this study since the 
group were not able to say if the failure of Lp to induce apoptosis in Ac was due to: (1) 
the inability of Lp itself to induce apoptosis; (2) the use of a different killing 
mechanism; or (3) the fact that Ac do not possess the adequate genetic program.  
With this study, we tried to clarify these answers and in order to do that we had to 
analyze the infected Ac in different conditions. Our results show that Ac has in fact the 
cellular machinery to undergo apoptosis and that after infection with Lp there is a high 
percentage of apoptotic Ac compared with the ones from the negative control. 
Although there are several remarkable similarities in the models of intracellular 
infection of macrophages and amoeba by Lp, the published literature affirms that the 
induction of apoptosis for evasion of the host only happens in macrophages. 
Considering our results, we can say that Lp may use similar molecular mechanisms to 
manipulate host cell processes of macrophages and protozoa and therefore hypothesize 
that the Lp process of killing and exiting the macrophages by apoptosis has evolved 
from the interaction with protozoa in the environment.  
By agarose gel electrophoresis, we were not able to detect DNA fragmentation of the 
infected Ac. However, according to Darzynkiewicz et al [128], the lack of evidence of 
apoptosis, detected by a particular method, is not evidence of the lack of apoptosis. 
There are numerous examples in the literature where cells die by a process resembling 
apoptosis which lacks one or more typical apoptotic features. Most frequently, DNA 
degradation stops after creation of 50–300-kb fragments, meaning there is no 
internucleosomal fragmentation seen and, therefore, fewer in situ DNA strand breaks 
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compared with classical apoptosis. The DNA laddering on gels for identification of 
apoptosis, fails to identify atypical apoptosis in such a situation. This is why application 
of more than one method, each based on a different principle stands a better chance of 
detecting atypical apoptosis than any single method.  
Considering this, our results do not exclude the possibility that the infected Ac are in 
fact undergoing apoptosis. 
For bacterial enumeration, the most commonly used direct plating method is the spread 
method, which consists in the spreading of one dilution of a bacterial suspension into a 
plate. Another plating method is the drop plate method, were the bacterial suspension is 
plated in drops and therefore one plate can have several dilutions. This method has 
some advantages over the spread plate method: it uses fewer materials; less time and 
effort are required to dispense the drops onto an agar plate than to spread an equivalent 
total sample volume into the agar plate and by distributing the sample in drops, colony 
counting can be done faster and perhaps more accurately. Even though it has been 
present in the laboratory for many years, the drop plate method has not been 
standardized. The objective of this research was to validate the use of the drop plate 
method for bacteria enumeration and to standardize a plating protocol. After counting 
and calculation of the CFU/ml for each method, the obtained results were similar which 
allowed us to conclude that the drop plate method could be used instead of the spread 
method for colony counting. Beside validation of the drop plate method, we tested the 
volume of the drops for 10 and 30µl. We chose the 30µl volume since it allows easier 
counting and to have four different dilutions per plate. 
For the determination of the intracellular replication rate of Lp Paris in Ac, we started by 
calculating the percentage of infectious bacteria which was 0.002%. This is a low 
infectivity value when compared with published data where an infectivity of 8% has 
been verified for Lp [137]. This value can be explained with the fact that after infection 
there was a high number of extracellular bacteria remaining in the medium. However, 
this value can also be due to the fact that the Ac lysis protocol may not have been 
effective on lysing the Ac completely, influencing the number of Lp considered for the 
calculus. Regarding the intracellular replication rate of Lp Paris in Ac, we verified that 
the yield of CFU for Lp Paris increased approximately 105-fold during a 24h infection 
in Ac. This value reflects a high rate of Lp replication in the Ac that is consistent with 
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our microscopic observations, where we were able to visualize a great number of 
bacteria after 24 hours post-infection. Additionally, we also know that this result was 
not influenced by the high number of extracellular bacteria because we have verified 
that Lp is not able to grow in the minimum medium used for the infection assays. 
However, if the Ac lysis protocol was not in fact effective it could have also influenced 
this result. 
Numerous methods have been employed to attempt to eradicate Lp from aquatic 
environments, with little success. These attempts, which include chemical biocides, 
overheating water, and UV irradiation, have been successful for short periods after 
which the bacteria can be again detected. It has been suggested that in order to eradicate 
Lp from aquatic environments continuous treatments effective against both the bacteria 
and the protozoan host should be employed [115]. 
Since free-living amoebae seem to play a crucial role for persistence and dispersal of 
Legionellaceae in the environment, and there is convincing evidence that intracellular 
multiplication of Lp in free-living amoebae is a prerequisite for the infection of humans 
[95], we believe that future studies should examine in greater detail the apoptotic 
process induced in Ac by Lp.  
Being this study a contribution in this field, we believe that a better understanding of 
such processes would help to develop novel strategies and targets to eradicate Lp from 
aquatic environments. The modulation of the Ac’s regulatory machinery, specifically 
their propensity to die in response to Lp infection through blocking the Ac apoptosis 
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Appendix 1  
 
     




Preparation of the Buffered Charcoal Yeast Extract (BCYE) agar 
 
1. Suspend 2.77g of Legionella CYE Agar Base (OXOID) in 100ml of distilled 
water. 
2. In a heat plate, bring to the boil to dissolve completely. Keep agitating. 
3. Once the solution is boiling, sterilize it in an autoclave at 120ºC, for 20min. 
4. After the sterilization, wait for the temperature to decrease to 60ºC. 
5. Add the Legionella growth supplement (OXOID). 
6. Distribute the medium into Petri dishes (20ml of medium/plate). The following 
step has to be done in a laminar flow cabinet or near a Bunsen burner to assure 
the sterility of the medium. 
7. Store the plates at 2 – 8ºC. 




     




Preparation of the Peptone-Yeast Extract-Glucose (PYG) medium 
 
1. Suspend in 950ml of distilled water: 
 1g Trisodium citrate (AppliChem) 
 20g Bactotrypone (Biokar Diagnostics) 
 1g Yeast extract (Biokar Diagnostics) 
 18g Glucose (AppliChem) 
2. Add to the previous solution: 
 8ml CaCl2 0.05M 
 10ml KH2PO4 0.25M 
 10ml MgSO4 0.4M 
 10ml Na2HPO4 0.25M 
 10ml Iron Pyrophosphate 0.005M 
3. Agitate. 
4. Sterilize the solution using a vacuum filtration system, with a 0.22µm filter 
(Millipore). 
5. Sterility test: after filtration, incubate 3ml of the medium at 37ºC, for one week 




     




Preparation of the ACES-buffered yeast extract (AYE) broth 
 
1. Suspend in 450ml of distilled water: 
 5g ACES (AppliChem) 
 5g Yeast extract (Biokar Diagnostics) 
2. Set the pH to 6.9. 
3. Add 0.2g of L-cystein (AppliChem). 
4. Separately, in a heat plate, dissolve 0.125g of Iron Pyrophosphate (Sigma) in 
50ml of distilled water. 
5. Add the Iron Pyrophosphate solution to the solution of step 2. 
6. Agitate. 
7. Sterilize the solution using a vacuum filtration system, with a 0.22µm filter 
(Millipore). 
8. Sterility test: after filtration, incubate 3ml of the medium at 37ºC, for one week 




     




Preparation of the Minimum Medium (MM) 
 
1. Suspend 1g of Trisodium citrate (AppliChem) in 950ml of distilled water. 
2. Add to the previous solution: 
 8ml CaCl2 0.05M 
 10ml KH2PO4 0.25M 
 10ml MgSO4 0.4M 
 10ml Na2HPO4 0.25M 
 10ml Iron Pyrophosphate 0.005M 
3. Agitate. 
4. Sterilize the solution using a vacuum filtration system, with a 0.22µm filter 
(Millipore). 
5. Sterility test: after filtration, incubate 3ml of the medium at 37ºC, for one 




     




Protocol for Ac monolayers lysis 
 
For 1 hour post-infection: 
 
1. Harvest the Ac and divide the volume into 3 Eppendorf tubes of 1.5ml. 
2. Centrifuge for 5 minutes at 19280 x g. 
3. Vortex at maximum speed for 1 minute. 
4. Pass the suspension through a syringe of 27G gauge. 
5. Collect the total volume to a sterile Falcon tube of 15ml. 
 
For 24 hours post-infection: 
 
1. Harvest the Ac and divide the volume into 3 Eppendorf tubes of 1.5ml. 
2. Vortex at maximum speed for 1 minute. 
3. Centrifuge for 5 minutes at 19280 x g. 
4. Vortex at maximum speed for 1 minute. 
5. Collect the total volume to a sterile Falcon tube of 15ml. 
 
 
     
 
 
 
